Minimal time to successful intercourse after sildenafil citrate: Results of a randomized, double-blind, placebo-controlled trial

被引:62
|
作者
Padma-Nathan, H
Stecher, VJ
Sweeney, M
Orazem, J
Tseng, LJ
deRiesthal, H
机构
[1] Male Clin, Beverly Hills, CA 90212 USA
[2] Univ So Calif, Keck Sch Med, Dept Urol, Los Angeles, CA USA
[3] Pfizer Inc, New York, NY USA
关键词
D O I
10.1016/S0090-4295(03)00567-3
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objectives. To determine the minimal time to successful intercourse after taking sildenafil citrate for erectile dysfunction (ED). Methods. Male patients with ED (mean age 60 years; mean ED duration 7.0 years) who were successfully treated with sildenafil (100 mg) for 2 months or longer were randomized to sildenafil (n = 115) or placebo (n = 113) for 4 weeks of double-blind treatment. Using a stopwatch, patients recorded the time needed to obtain an erection hard enough for sexual intercourse after taking the study drug at least 2 hours after eating. Results. Within 14 and 20 minutes of sildenafil dosing, 35% and 51% of sildenafil-treated patients, respectively, versus 22% and 30% of placebo-treated patients, respectively, had an erection that led to successful intercourse (P < 0.05 for both). The median time to erection leading to successful intercourse after sildenafil dosing was 36 minutes compared with 141 minutes for placebo. Conclusions. In this study, slightly more than one half of a population of prior sildenafil responders achieved an erection that led to successful sexual intercourse within 20 minutes of sildenafil administration, suggesting that the onset of action of sildenafil can be less than 30 minutes in men with ED.
引用
收藏
页码:400 / 403
页数:4
相关论文
共 50 条
  • [21] Alverine citrate fails to relieve the symptoms of irritable bowel syndrome: results of a double-blind, randomized, placebo-controlled trial
    Mitchell, SA
    Mee, AS
    Smith, GD
    Palmer, KR
    Chapman, RW
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2002, 16 (06) : 1187 - 1195
  • [22] RESULTS OF A PROSPECTIVE RANDOMIZED DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL EVALUATING THE USE OF PROPHYLACTIC SILDENAFIL CITRATE (SC) DURING RADIOTHERAPY (RT) IN THE TREATMENT OF PROSTATE CANCER
    Mulhall, John P.
    Cox, Brett
    Kollmeier, Marisa
    Dunn, Rebekah
    Baser, Raymond
    Pei, Xin
    Shaha, Daniel
    Ennis, Ronald
    Bar-Chama, Natan
    Stock, Richard
    Zelefsky, Michael
    [J]. JOURNAL OF UROLOGY, 2013, 189 (04): : E623 - E624
  • [23] Effects of doxycycline on progression of osteoarthritis - Results of a randomized, placebo-controlled, double-blind trial
    Brandt, KD
    Mazzuca, SA
    Katz, BP
    Lane, KA
    Buckwalter, KA
    Yocum, DE
    Wolfe, F
    Schnitzer, TJ
    Moreland, LW
    Manzi, S
    Bradley, JD
    Sharma, L
    Oddis, CV
    Hugenberg, ST
    Heck, LW
    [J]. ARTHRITIS AND RHEUMATISM, 2005, 52 (07): : 2015 - 2025
  • [24] Antithrombin therapy for severe preeclampsia: Results of a double-blind, randomized, placebo-controlled trial
    Maki, M
    Kobayashi, T
    Terao, T
    Ikenoue, T
    Satoh, K
    Nakabayashi, M
    Sagara, Y
    Kajiwara, Y
    Urata, M
    [J]. THROMBOSIS AND HAEMOSTASIS, 2000, 84 (04) : 583 - 590
  • [25] NALOXONE AMELIORATES THE PRURITUS OF CHOLESTASIS - RESULTS OF A DOUBLE-BLIND RANDOMIZED PLACEBO-CONTROLLED TRIAL
    BERGASA, NV
    ALLING, DW
    TALBOT, TL
    SWAIN, MG
    FRIED, MW
    FONG, TL
    YURDAYDIN, C
    SCHMITT, JM
    WALKER, EC
    TURNER, ML
    JONES, EA
    [J]. HEPATOLOGY, 1992, 16 (04) : A152 - A152
  • [26] Pregabalin for the treatment of fibromyalgia syndrome - Results of a randomized, double-blind, placebo-controlled trial
    Crofford, LJ
    Rowbotham, MC
    Mease, PJ
    Russell, IJ
    Dworkin, RH
    Corbin, AE
    Young, JP
    LaMoreaux, LK
    Martin, SA
    Sharma, U
    [J]. ARTHRITIS AND RHEUMATISM, 2005, 52 (04): : 1264 - 1273
  • [27] Results of a randomized, double-blind, placebo-controlled trial of lorcaserin in cocaine use disorder
    McCann, David J.
    Chen, Hegang H.
    Devine, Eric G.
    Gyaw, Shwe
    Ramey, Tatiana
    [J]. DRUG AND ALCOHOL DEPENDENCE, 2024, 255
  • [28] Inhalation aromatherapy during radiotherapy: Results of a placebo-controlled double-blind randomized trial
    Graham, PH
    Browne, L
    Cox, H
    Graham, J
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (12) : 2372 - 2376
  • [29] Establishing optimal selenium status: results of a randomized, double-blind, placebo-controlled trial
    Hurst, Rachel
    Armah, Charlotte N.
    Dainty, Jack R.
    Hart, Dave J.
    Teucher, Birgit
    Goldson, Andrew J.
    Broadley, Martin R.
    Motley, Amy K.
    Fairweather-Tait, Susan J.
    [J]. AMERICAN JOURNAL OF CLINICAL NUTRITION, 2010, 91 (04): : 923 - 931
  • [30] Methotrexate in Crohn's disease: Results of a randomized, double-blind, placebo-controlled trial
    Arora, S
    Katkov, W
    Cooley, J
    Kemp, JA
    Johnston, DE
    Schapiro, RH
    Podolsky, D
    [J]. HEPATO-GASTROENTEROLOGY, 1999, 46 (27) : 1724 - 1729